- Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Providers & Services industry and the overall market, HOOPER HOLMES INC's return on equity significantly trails that of both the industry average and the S&P 500.
- 36.56% is the gross profit margin for HOOPER HOLMES INC which we consider to be strong. Regardless of HH's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, HH's net profit margin of -42.11% significantly underperformed when compared to the industry average.
- HOOPER HOLMES INC has improved earnings per share by 40.0% in the most recent quarter compared to the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, HOOPER HOLMES INC reported poor results of -$0.17 versus -$0.11 in the prior year.
- The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Providers & Services industry. The net income increased by 43.8% when compared to the same quarter one year prior, rising from -$5.00 million to -$2.81 million.
- This stock has increased by 27.08% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the future course of this stock, we feel that the risks involved in investing in HH do not compensate for any future upside potential, despite the fact that it has seen nice gains over the past 12 months.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 41.93 points (-0.2%) at 17,071 as of Monday, Sept. 29, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,274 issues advancing vs. 1,814 declining with 136 unchanged. The Health Services industry as a whole closed the day up 0.3% versus the S&P 500, which was down 0.3%. Top gainers within the Health Services industry included VirtualScopics ( VSCP), up 2.2%, Electromed ( ELMD), up 4.6%, BSD Medical ( BSDM), up 9.5%, Hooper Holmes ( HH), up 6.8% and Bovie Medical ( BVX), up 3.5%. TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today: Hooper Holmes ( HH) is one of the companies that pushed the Health Services industry higher today. Hooper Holmes was up $0.04 (6.8%) to $0.63 on light volume. Throughout the day, 73,739 shares of Hooper Holmes exchanged hands as compared to its average daily volume of 119,000 shares. The stock ranged in a price between $0.58-$0.63 after having opened the day at $0.59 as compared to the previous trading day's close of $0.59. Hooper Holmes, Inc., together with its subsidiaries, provides health risk assessment services to the life insurance and health industries in the United States. The company operates through three segments: Health and Wellness, Heritage Labs, and Hooper Holmes Services. Hooper Holmes has a market cap of $43.2 million and is part of the health care sector. Shares are up 11.3% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Hooper Holmes a buy, no analysts rate it a sell, and none rate it a hold. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreet Ratings rates Hooper Holmes as a sell. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity. Highlights from TheStreet Ratings analysis on HH go as follows: